PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Molecular & Structural Bioscience, School of Life Sciences, Keele University Staffordshire, ST5 5BG, United Kingdom.\', \'School of Biomedical Sciences, Institute of Clinical Sciences Medical School University of Birmingham, Birmingham, B15 2TT, United Kingdom.\', \'School of Pharmacy and Bioengineering, Keele University Staffordshire, ST5 5BG, United Kingdom. Electronic address: a.richardson1@keele.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0006-291X(20)32099-410.1016/j.bbrc.2020.11.055
?:doi
?:hasPublicationType
?:journal
  • Biochemical and biophysical research communications
is ?:pmid of
?:pmid
?:pmid
  • 33239166
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.087
?:rankingScore_hIndex
  • 237
is ?:relation_isRelatedTo_publication of
?:title
  • Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all